This study is completed in Switzerland. It is testing LIVIA for Prolonged Grief Disorder.
Prolonged grief disorderBehavioralOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether LIVIA may be useful for adults experiencing prolonged grief disorder.
What would participation involve?
Participants may use LIVIA, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Switzerland.
Who is it mainly for?
This study appears to be mainly for adults with prolonged grief disorder.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: May 6, 2022
Recruitment status
Completed
Enrollment listed in the registry
64
Sponsor
Debrot Anik
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Switzerland
Age range
Over 18 Years
Official registry ID
NCT05219760
Official title
LIVIA 2.0: A Randomized Controlled Trial of Two French Internet Intervention for Adults Struggling With Prolonged Grief Symptoms After the Loss of a Close One (by Bereavement or Separation/Divorce)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05219760. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
Completed
Lausanne
Registry details
Registry conditions (original wording)
Prolonged Grief Disorder
FAQ
Questions about this study
Who is behind this study?
The study sponsor is Debrot Anik.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as completed.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.